BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 17430426)

  • 1. Oral phosphodiesterase-5 inhibitors: effect of heme oxygenase inhibition on cGMP signalling in rat cavernous tissue.
    Abdel Aziz MT; Mostafa T; Atta H; Rashed L; Marzouk SA; Obaia EM; Sabry D; Hassouna AA; El-Shehaby AM; Abdel Aziz AT
    Andrologia; 2007 Apr; 39(2):66-70. PubMed ID: 17430426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of PDE5 inhibitors in heme oxygenase-cGMP relationship in rat cavernous tissues.
    Aziz MT; Mostafa T; Atta H; Rashed L; Marzouk SA; Obaia EM; Sabry D; Hassouna AA; El-Shehaby AM; Aziz AT
    J Sex Med; 2008 Jul; 5(7):1636-45. PubMed ID: 18208506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of phosphodiesterase 5 (PDE 5) inhibit the nerve-induced release of nitric oxide from the rabbit corpus cavernosum.
    Hallén K; Wiklund NP; Gustafsson LE
    Br J Pharmacol; 2007 Feb; 150(3):353-60. PubMed ID: 17179943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of phosphodiesterase-5 inhibitors on hypoxic pulmonary vasoconstriction and pulmonary artery cytokine expression.
    Tsai BM; Turrentine MW; Sheridan BC; Wang M; Fiore AC; Brown JW; Meldrum DR
    Ann Thorac Surg; 2006 Jan; 81(1):272-8. PubMed ID: 16368379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro effects of PDE5 inhibitors sildenafil, vardenafil and tadalafil on isolated human ureteral smooth muscle: a basic research approach.
    Gratzke C; Uckert S; Kedia G; Reich O; Schlenker B; Seitz M; Becker AJ; Stief CG
    Urol Res; 2007 Feb; 35(1):49-54. PubMed ID: 17102958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of heme oxygenase-1 (HO-1) activity in the cavernous tissues of sildenafil citrate-treated rats.
    Aziz MT; Al-Asmar MF; Mostafa T; Atta H; Rashed L; Sabry D; Ashour S; Aziz AT
    Asian J Androl; 2007 May; 9(3):377-81. PubMed ID: 17486279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential effects of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, and tadalafil in rat aorta.
    Teixeira CE; Priviero FB; Webb RC
    J Pharmacol Exp Ther; 2006 Feb; 316(2):654-61. PubMed ID: 16204472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the phosphodiesterase 5 inhibitors sildenafil, tadalafil and vardenafil on rat anococcygeus muscle: functional and biochemical aspects.
    Toque HA; Priviero FB; Zemse SM; Antunes E; Teixeira CE; Webb RC
    Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):358-66. PubMed ID: 18986324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heme oxygenase vs. nitric oxide synthase in signaling mediating sildenafil citrate action.
    Abdel Aziz MT; El-Asmer MF; Mostafa T; Mostafa S; Atta H; Aziz Wassef MA; Fouad H; Rashed L; Sabry D; Mahfouz S
    J Sex Med; 2007 Jul; 4(4 Pt 2):1098-107. PubMed ID: 17627722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of tritiated sildenafil, tadalafil, or vardenafil to the phosphodiesterase-5 catalytic site displays potency, specificity, heterogeneity, and cGMP stimulation.
    Blount MA; Beasley A; Zoraghi R; Sekhar KR; Bessay EP; Francis SH; Corbin JD
    Mol Pharmacol; 2004 Jul; 66(1):144-52. PubMed ID: 15213306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High biochemical selectivity of tadalafil, sildenafil and vardenafil for human phosphodiesterase 5A1 (PDE5) over PDE11A4 suggests the absence of PDE11A4 cross-reaction in patients.
    Weeks JL; Zoraghi R; Beasley A; Sekhar KR; Francis SH; Corbin JD
    Int J Impot Res; 2005; 17(1):5-9. PubMed ID: 15538396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of direct relaxant effect of sildenafil, tadalafil and vardenafil on corpus cavernosum.
    Lau LC; Adaikan PG
    Eur J Pharmacol; 2006 Jul; 541(3):184-90. PubMed ID: 16777087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation of phosphodiesterase-5 is promoted by a conformational change induced by sildenafil, vardenafil, or tadalafil.
    Bessay EP; Zoraghi R; Blount MA; Grimes KA; Beasley A; Francis SH; Corbin JD
    Front Biosci; 2007 Jan; 12():1899-910. PubMed ID: 17127429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The phosphodiesterase inhibitory selectivity and the in vitro and in vivo potency of the new PDE5 inhibitor vardenafil.
    Saenz de Tejada I; Angulo J; Cuevas P; Fernández A; Moncada I; Allona A; Lledó E; Körschen HG; Niewöhner U; Haning H; Pages E; Bischoff E
    Int J Impot Res; 2001 Oct; 13(5):282-90. PubMed ID: 11890515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of phosphodiesterase 5 inhibition in erectile dysfunction.
    Rosen RC; Kostis JB
    Am J Cardiol; 2003 Nov; 92(9A):9M-18M. PubMed ID: 14609619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 46-amino acid segment in phosphodiesterase-5 GAF-B domain provides for high vardenafil potency over sildenafil and tadalafil and is involved in phosphodiesterase-5 dimerization.
    Blount MA; Zoraghi R; Ke H; Bessay EP; Corbin JD; Francis SH
    Mol Pharmacol; 2006 Nov; 70(5):1822-31. PubMed ID: 16926278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative relaxing effects of sildenafil, vardenafil, and tadalafil in human corpus cavernosum: contribution of endogenous nitric oxide release.
    Toque HA; Priviero FB; Teixeira CE; Claudino MA; Baracat JS; Fregonesi A; De Nucci G; Antunes E
    Urology; 2009 Jul; 74(1):216-21. PubMed ID: 19371941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tadalafil, a long-acting type 5 phosphodiesterase isoenzyme inhibitor, improves neurological functional recovery in a rat model of embolic stroke.
    Zhang L; Zhang Z; Zhang RL; Cui Y; LaPointe MC; Silver B; Chopp M
    Brain Res; 2006 Nov; 1118(1):192-8. PubMed ID: 16959227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel water-soluble curcumin derivative mediating erectile signaling.
    Abdel Aziz MT; El Asmer MF; Rezq A; Kumosani TA; Mostafa S; Mostafa T; Atta H; Abdel Aziz Wassef M; Fouad HH; Rashed L; Sabry D; Hassouna AA; Senbel A; Abdel Aziz A
    J Sex Med; 2010 Aug; 7(8):2714-22. PubMed ID: 21711478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nebivolol potentiates the efficacy of PDE5 inhibitors to relax corpus cavernosum and penile arteries from diabetic patients by enhancing the NO/cGMP pathway.
    Martínez-Salamanca JI; La Fuente JM; Cardoso J; Fernández A; Cuevas P; Wright HM; Angulo J
    J Sex Med; 2014 May; 11(5):1182-92. PubMed ID: 24877179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.